Faron details clinical plans for MDS drug; Cara to seek ‘strategic’ options

Plus, news about CSL Vifor, Akebia and Pan Cancer T:

Faron gets FDA go-ahead for streamlined registrational path: The company said the regulator “acknowledged the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

COMPASS Pathways Secures Large Funding To Fund Phase 3 Psilocybin Assisted Therapy Trial

COMPASS Pathways plc (Nasdaq: CMPS) made a significant announcement that could secure most, or all, of the funding needed to conduct their ongoing Phase 3

August 17, 2023

identifeye HEALTH Launches AI-Powered Retinal Imaging System

What You Should Know: – identifeye HEALTH, a medical diagnostics company pioneering AI and automation in healthcare, has launched the identifeye System, an AI-powered retinal

October 19, 2024

Novartis to seek accelerated approval for oral complement inhibitor in rare kidney disease

Novartis said that its experimental complement inhibitor iptacopan reduced the buildup of protein in the urine of patients with IgA nephropathy significantly more than a

October 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.